ORIC FY 2025 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ORICORIC Pharmaceuticals, Inc.

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$143M

Net Income

-$129M

EPS (Diluted)

$-1.47

Cash Flow

Operating Cash Flow

-$113M

Free Cash Flow

-$114M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$411M

Total Liabilities

$27M

Stockholders' Equity

$384M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$1M	-10.2%
Operating Income	-$143M	-$143M	-0.1%
Net Income	-$129M	-$128M	-1.3%